Oncology

Latest News

The new guideline is the NCCN’s first patient resource on the topic of cancer genetics and hereditary cancer risk. | Image credit: Connect world - stock.adobe.com

NCCN Publishes Patient Guidance on Genetic Testing for Cancer Risk

By Rose McNulty

January 16th 2025

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and testing for inherited genetic mutations linked with increased cancer risk.

Patient receiving lung cancer screening results | Image Credit: Nattakorn - stock.adobe.com

Lung Cancer Screening Facilities Least Accessible to American Indian/Alaska Native Patients, Rural Communities

By Brooke McCormick

January 13th 2025

Child standing on scale | Image Credit: Protsenko Dmitriy - stock.adobe.com

Obesity at Cancer Diagnosis Linked to Worse Survival Outcomes in Pediatric Patients

By Brooke McCormick

January 13th 2025

Houston, TX | Image credit: Kovacs – stock.adobe.com

Decisions and Precision in Value-Based Cancer Care

By Hayden E. Klein

January 7th 2025

FDA approved. | Image Credit: Pawel - stock.adobe.com .jpeg

FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors

By Pearl Steinzor

January 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Miruna Sasu, PhD, MBA, COTA Healthcare

May 25th 2022

Dr Miruna Sasu: The FDA Can Help to Clean Up and Improve RWD Capture

Mary Caffrey Maggie L. Shaw

Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses 3 ways in which the FDA can provide, and has provided, assistance on the capture of real-word data (RWD) in electronic medical records.

Contributor: It’s Time for Drug Middlemen to Own Up and Pass the Savings to Consumers

May 23rd 2022

Contributor: It’s Time for Drug Middlemen to Own Up and Pass the Savings to Consumers

Kathy Oubre, MS

The dysfunction with pharmacy benefit managers (PBMs) is so troublesome that the Federal Trade Commission (FTC) is currently investigating how they have driven up costs. Until May 25, the FTC is holding a public comment period on PBM practices.

Oncology Drugs Dominate Medical Benefit Spend

May 18th 2022

Oncology Drugs Dominate Medical Benefit Spend

Laura Joszt, MA

Across commercial insurance, Medicare, and Medicaid populations, oncology is the top category of spend, and the drug pipeline has increasing specific and complex therapies.

Miruna Sasu, PhD, MBA, COTA Healthcare

May 15th 2022

Dr Miruna Sasu: Real-world Data Must Represent Diversity

Mary Caffrey Maggie L. Shaw

Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, delves into how real-world data and evidence generation have changed, both within the past year and since the beginning of the COVID-19 pandemic.

Leah Owens, DNP, RN

May 12th 2022

Leah Owens Explains Tennessee Oncology's Next Steps to Maintain Quality Care Post OCM

Hayden E. Klein

After the Oncology Care Model (OCM) expires at the end of June, Tennessee Oncology will take what it learned from the model and apply it to commercial value-based care arrangements and potentially the next Medicare model, said Leah Owens, DNP, RN, executive director of care transformation at Tennessee Oncology.

May 10th 2022

Assessing Surveillance Utilization and Value in Commercially Insured Patients With Colorectal Cancer

Kangho Suh, PharmD, PhD Veena Shankaran, MD, MS Aasthaa Bansal, PhD

Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but higher costs.

May 4th 2022

Rising Use of Surveillance Colonoscopy and Potential Impacts

Megan A. Adams, MD, JD, MSc Joel H. Rubenstein, MD, MSc Rob Holleman, MPH Rachel Lipson, MA Mandi L. Klamerus, MPH Shannon Zoulek, MD Sameer D. Saini, MD, MS

The proportion of colonoscopies performed for postpolypectomy surveillance has increased significantly, particularly among older patients with limited life expectancy, raising concern for possible overuse.

May 3rd 2022

Patterns of Opioid Use in Commercially Insured Patients With Cancer

Tham Thi Le, PhD, MPH Sean P. Fleming, MSW Linda Simoni-Wastila, PhD, MSPH

Among the fewer than half of patients with cancer who received opioid fills, a relatively small proportion (2.5%) had potentially problematic opioid use.

Newspapers

May 2nd 2022

What We're Reading: Decision Date on COVID-19 Vaccine for Young Children; AAP Guidance Review; FDA Rebuffs 2 Cancer Therapies

The FDA sets a tentative date for a decision on authorizing a COVID-19 vaccine in children under 5 years of age; the American Academy of Pediatrics will review all of its guidance for unproven race-based recommendations contributing to health disparities; the FDA rejects 2 China-tested cancer treatments.

money being allocated for a number of health realted causes

May 2nd 2022

Crowdfunding for Cancer: What Financial Toxicity Among Young Adults Says About the US Health Care System

Skylar Jeremias

Although crowdfunding can be a financial lifeline for young adult patients with serious medical conditions, the nuances regarding the need for and the long-term impact of crowdfunding exposes a facet of the US health care system that must be addressed.

Elaine Goodman, MD, MBA

April 26th 2022

Dr Elaine Goodman: Why Health Care Systems Should Consider the Patient Perspective

Hayden E. Klein

When clinicians consider the patient journey from beginning to end, they begin to understand how difficult it is for patients to access care, said Elaine Goodman, MD, MBA, clinical lead for population health management, Mass General Brigham.

AON Partners With Annexus Health to Help Patients Gain Financial Assistance

April 19th 2022

AON Partners With Annexus Health to Help Patients Gain Financial Assistance

The CEO of the American Oncology Network cited the growing need for financial assistance in announcing the partnership.

We Need a Cancer Patient Bill of Rights

April 18th 2022

We Need a Cancer Patient Bill of Rights

Joseph Alvarnas, MD

From the editor-in-chief of Evidence-Based Oncology.

Conference Coverage: ACCC 2022 AMCCBS

April 14th 2022

Conference Coverage: ACCC 2022 AMCCBS

Coverage from the Association of Community Cancer Centers 2022 Annual Meeting and Cancer Center Business Summit, held in Washington, DC, March 2-4.

Conference Coverage: Cholangiocarcinoma Foundation 2022

April 14th 2022

Conference Coverage: Cholangiocarcinoma Foundation 2022

Coverage from the 2022 annual meeting of the Cholangiocarcinoma Foundation, which met February 23-25 in Salt Lake City, Utah.

What’s Next for Real-World Evidence in Oncology?

April 13th 2022

What’s Next for Real-World Evidence in Oncology?

Michael Vasconcelles, MD Brad Jordan, PhD

Recent steps by FDA to promote the use of real-world evidence are to be commended, but the future demands a broader vision that makes greater use of growing sources of health care information.

Sharpless Steps Down as NCI Director

April 4th 2022

Sharpless Steps Down as NCI Director

Norman E. “Ned” Sharpless, MD, is departing shortly after the launch of Cancer Moonshot 2.0, an initiative that aims to reduce the cancer death rate by at least half over the next 25 years while improving the experience for all those affected by cancer.

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

March 15th 2022

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

Kashyap Patel, MD Hirangi Mukhi, BS Anjana Patel, BSc Niyati Nathwani, MD Dhwani Mehta, MS Jennifer Sherak, MBA Natasha Clinton, MSN, APRN, AOCNP Holly Pisarik, JD Benjamin Brown, BS Sara Rogers, PharmD Mary Kruczynski Nicolas Ferreyros, BA Ted Okon, MBA

No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.

Patel et al, Appendix B

March 15th 2022

Patel et al, Appendix B

COA 2022 Preview: Leaders Excited About Seeing Colleagues in Person

March 14th 2022

COA 2022 Preview: Leaders Excited About Seeing Colleagues in Person

The first in-person Community Oncology Alliance (COA) meeting in 2 years will feature sessions on practice management, health disparities, and more. A virtual option is available.

March 9th 2022

Oncology Alternative Payment Models: Lessons From Commercial Insurance

Elizabeth Shaughnessy, MA David C. Johnson, MD, MPH Aaron J. Lyss, MBA Ravi B. Parikh, MD, MPP Steven R. Peskin, MD, MBA, MACP Blase N. Polite, MD, MPP Julie A. Royalty Bhuvana Sagar, MD, MBA Erin Smith, JD Lindee Goh, PhD

Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date.

Purva Rawal, PhD

February 21st 2022

CMS Official Cites OCM as Example of Biosimilar Success

Purva Rawal, PhD, senior advisor and chief strategy officer, Center for Medicare and Medicaid Innovation, addressed attendees at the Association for Accessible Medicines' Access! annual meeting, held in Orlando, Florida, February 15-16.

Joseph Alvarnas, MD

February 16th 2022

From the Editor-in-Chief: From the Earth to the Moon (and Back)

Joseph Alvarnas, MD

The president’s aim is a 50% reduction in age-adjusted cancer deaths by 2047. This goal seems audacious, but it is likely achievable.

DNA.

February 15th 2022

Tumor Mutational Burden May Help Predict Immunotherapy Response in Metastatic NSCLC

Matthew Gavidia

Response to immunotherapy and survival outcomes were found to be significantly associated with tumor mutational burden in patients with stage IV non-small cell lung cancer.

Emory’s Winship Joins AccessHope as Collaboration Partner

February 14th 2022

Emory’s Winship Joins AccessHope as Collaboration Partner

AccessHope is a program that allows patients and community oncologists to tap into the expertise of City of Hope, often through electronic sharing of records so the patient does not have to travel.

February 14th 2022

From Our Partners: Schleicher, Dickson Take New Roles at Tennessee Oncology

Hayden E. Klein Mary Caffrey

The changes come as Tennessee Oncology must now plan for a gap between the Oncology Care Model and a future alternative payment model from CMS.

What We're Reading

February 2nd 2022

What We’re Reading: Cancer Moonshot Returns; New Omicron Subvariant; Drug Overdose Suicide Rates

President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.

COA Survey: Practices Find OCM a Success; Some Added Services May Be at Risk

January 31st 2022

COA Survey: Practices Find OCM a Success; Some Added Services May Be at Risk

The Oncology Care Model (OCM) is set to expire June 30, 2022. With no successor on the horizon, respondents to a recent survey by the Community Oncology Alliance (COA) say features such as dedicated navigators and weekend appointments could be reduced or lost if revenues that supported them are eliminated.

January 11th 2022

Management of TRK Fusion Cancer: Evaluating Targeted Therapies - Participating Faculty

January 11th 2022

Diagnosis and Management of TRK Fusion Cancer

Shivaani Kummar, MD, FACP Antoine Italiano, MD, PhD Marcia S. Brose, MD, PhD Josh J. Carlson, PhD, MPH Sean D. Sullivan, PhD, MSc, RPh Ulrik Lassen, MD, PhD Noah Federman, MD

...

8 9 10 11 12 13 14 15 16

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions